Ginkgo Bioworks Holdings (DNA) — Financial Flexibility Index
Ginkgo Bioworks Holdings (DNA) has a Financial Flexibility Index of -0.08x as of March 2026. Free cash flow of $-44.50 Million (operating CF $-46.43 Million minus capex $1.93 Million) represents 0% of total liabilities ($589.92 Million). Check Ginkgo Bioworks Holdings strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ginkgo Bioworks Holdings Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Ginkgo Bioworks Holdings across 7 annual periods. See DNA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ginkgo Bioworks Holdings (2019–2025)
Year-by-year free cash flow to debt coverage for Ginkgo Bioworks Holdings. For the full company profile including market capitalisation, see Ginkgo Bioworks Holdings market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-163.39 Million | $-171.06 Million | $611.11 Million | ▲ +31.2% |
| 2024 | -0.39x | $-257.04 Million | $-319.58 Million | $661.39 Million | ▲ +13.3% |
| 2023 | -0.45x | $-254.70 Million | $-295.50 Million | $568.19 Million | ▼ -80.1% |
| 2022 | -0.25x | $-199.93 Million | $-252.20 Million | $803.04 Million | ▲ +36.5% |
| 2021 | -0.39x | $-197.30 Million | $-253.82 Million | $503.61 Million | ▼ -3.0% |
| 2020 | -0.38x | $-78.01 Million | $-135.83 Million | $205.10 Million | ▼ -231.2% |
| 2019 | -0.11x | $-22.44 Million | $-44.66 Million | $195.47 Million | — |